Mankind Pharma Limited (NSE: MANKIND)
India
· Delayed Price · Currency is INR 2,581.80
+100.20 (4.04%)
Feb 3, 2025, 3:30 PM IST
Mankind Pharma Market Cap
Mankind Pharma has a market cap or net worth of 1.05 trillion as of February 4, 2025. Its market cap has increased by 22.81% in one year.
Market Cap
1.05T
Enterprise Value
1.01T
Revenue
116.41B
Ranking
n/a
PE Ratio
50.29
Stock Price
2,581.80
Market Cap Chart
Since May 9, 2023, Mankind Pharma's market cap has increased from 569.76B to 1.05T, an increase of 85.02%. That is a compound annual growth rate of 42.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2025 | 1,054.15B | -11.29% |
| Dec 31, 2024 | 1,188.36B | 49.64% |
| Dec 29, 2023 | 794.17B | 39.39% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,180.12B |
| Divi's Laboratories | 1,491.55B |
| Cipla | 1,162.56B |
| Apollo Hospitals Enterprise | 983.65B |
| Zydus Lifesciences | 981.88B |
| Aurobindo Pharma | 663.62B |
| Alkem Laboratories | 601.36B |
| Fortis Healthcare | 473.25B |